The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated blood back to the heart. Glucotrack calls its device, ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Goode, expressed enthusiasm about the results, indicating that this technology brings continuous glucose monitoring ... with diabetes. Glucotrack’s CBGM is a long-term, implantable system ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous blood ...